MACQUARIE GROUP LTD - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q4 2022$6,000
-76.9%
469
-52.4%
0.00%
Q3 2022$26,000
-3.7%
986
-32.7%
0.00%
Q2 2022$27,000
+12.5%
1,4640.0%0.00%
Q1 2022$24,000
+20.0%
1,4640.0%0.00%
Q4 2021$20,000
-25.9%
1,4640.0%0.00%
Q3 2021$27,000
-12.9%
1,4640.0%0.00%
Q2 2021$31,000
-24.4%
1,4640.0%0.00%
Q1 2021$41,000
-33.9%
1,464
-23.5%
0.00%
Q4 2020$62,000
+5.1%
1,9130.0%0.00%
Q3 2020$59,000
+90.3%
1,9130.0%0.00%
Q2 2020$31,000
+675.0%
1,913
+537.7%
0.00%
Q4 2018$4,000
-20.0%
3000.0%0.00%
Q3 2018$5,000
-44.4%
300
-50.0%
0.00%
Q4 2017$9,0006000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders